Estimation of glomerular filtration rates before and after orthotopic liver transplantation: evaluation of current equations.

PubWeight™: 3.46‹?› | Rank: Top 1%

🔗 View Article (PMID 14762871)

Published in Liver Transpl on February 01, 2004

Authors

Thomas A Gonwa1, Linda Jennings, Martin L Mai, Paul C Stark, Andrew S Levey, Goran B Klintmalm

Author Affiliations

1: Department of Transplantation, Mayo Clinic, Jacksonville, FL 32216, USA. Gonwa.Thomas@mayo.edu

Articles citing this

A new equation to estimate glomerular filtration rate. Ann Intern Med (2009) 71.41

Comparison of drug dosing recommendations based on measured GFR and kidney function estimating equations. Am J Kidney Dis (2009) 4.30

Chronic kidney disease and associated mortality after liver transplantation--a time-dependent analysis using measured glomerular filtration rate. J Hepatol (2014) 3.88

Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2. Am J Kidney Dis (2010) 3.87

Performance of creatinine-based GFR estimating equations in solid-organ transplant recipients. Am J Kidney Dis (2014) 2.80

Evaluating the performance of equations for estimating glomerular filtration rate. J Nephrol (2008) 1.95

Evaluation of the Chronic Kidney Disease Epidemiology Collaboration equation for estimating the glomerular filtration rate in multiple ethnicities. Kidney Int (2010) 1.81

Serum sodium, renal function, and survival of patients with end-stage liver disease. J Hepatol (2010) 1.62

Recipient survival and graft survival are not diminished by simultaneous liver-kidney transplantation: an analysis of the united network for organ sharing database. Liver Transpl (2012) 1.54

Development and validation of GFR-estimating equations using diabetes, transplant and weight. Nephrol Dial Transplant (2009) 1.46

Hepatorenal syndrome: the 8th International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care (2012) 1.30

Performance of chronic kidney disease epidemiology collaboration creatinine-cystatin C equation for estimating kidney function in cirrhosis. Hepatology (2013) 1.18

Comparison of cystatin C and creatinine-based glomerular filtration rate formulas with 51Cr-EDTA clearance in patients with cirrhosis. Clin J Am Soc Nephrol (2010) 1.12

Gender disparity in liver transplant waiting-list mortality: the importance of kidney function. Liver Transpl (2010) 1.03

Risk of end-stage renal disease among liver transplant recipients with pretransplant renal dysfunction. Am J Transplant (2012) 1.00

Current concepts in the diagnosis and classification of renal dysfunction in cirrhosis. Am J Nephrol (2013) 0.97

Serum creatinine in patients with advanced liver disease is of limited value for identification of moderate renal dysfunction: are the equations for estimating renal function better? Can J Gastroenterol (2006) 0.96

Role of cytochrome P450 2C8 and 2J2 genotypes in calcineurin inhibitor-induced chronic kidney disease. Pharmacogenet Genomics (2008) 0.95

Simultaneous liver-kidney versus liver transplantation alone in patients with end-stage liver disease and kidney dysfunction not on dialysis. Transplant Proc (2011) 0.92

Propensity score-based survival benefit of simultaneous liver-kidney transplant over liver transplant alone for recipients with pretransplant renal dysfunction. Liver Transpl (2016) 0.88

Risk factors for end-stage kidney disease after pediatric liver transplantation. Am J Transplant (2012) 0.87

Serum cystatin C level is a useful marker for the evaluation of renal function in patients with cirrhotic ascites and normal serum creatinine levels. Korean J Hepatol (2011) 0.87

Predicting the development of acute kidney injury in liver cirrhosis--an analysis of glomerular filtration rate, proteinuria and kidney injury biomarkers. Aliment Pharmacol Ther (2013) 0.85

Predicting survival after living and deceased donor liver transplantation in adult patients with acute liver failure. J Gastroenterol (2012) 0.84

The relationship between preoperative creatinine clearance and outcomes for patients undergoing liver transplantation: a retrospective observational study. BMC Nephrol (2013) 0.83

Using serum α-fetoprotein for prognostic prediction in patients with hepatocellular carcinoma: what is the most optimal cutoff? PLoS One (2015) 0.83

Difference between CKD-EPI and MDRD equations in calculating glomerular filtration rate in patients with cirrhosis. World J Gastroenterol (2011) 0.82

Renal impairment after liver transplantation - a pilot trial of calcineurin inhibitor-free vs. calcineurin inhibitor sparing immunosuppression in patients with mildly impaired renal function after liver transplantation. Eur J Med Res (2009) 0.82

Chronic kidney disease after liver transplantation in human immunodeficiency virus/hepatitis C virus-coinfected recipients versus human immunodeficiency virus-infected recipients without hepatitis C virus: results from the National Institutes of Health multi-site study. Liver Transpl (2013) 0.81

The role of everolimus in liver transplantation. Clin Exp Gastroenterol (2014) 0.79

GFR Estimating Equations and Liver Disease. Adv Chronic Kidney Dis (2015) 0.79

Evaluation of renal function in patients with cirrhosis: where are we now? World J Gastroenterol (2014) 0.78

Gender-based disparities in access to and outcomes of liver transplantation. World J Hepatol (2015) 0.78

Difficulties in diagnosing acute kidney injury post liver transplantation using serum creatinine based diagnostic criteria. World J Hepatol (2014) 0.77

Serum Cystatin C as an Indicator of Renal Function and Mortality in Liver Transplant Recipients. Transplantation (2015) 0.77

Chronic Kidney Disease and Related Long-Term Complications After Liver Transplantation. Adv Chronic Kidney Dis (2015) 0.77

Kidney Failure and Liver Allocation: Current Practices and Potential Improvements. Adv Chronic Kidney Dis (2015) 0.76

Assessing creatinine clearance from modification of diet in renal disease study equations in the ADEMEX cohort: limitations and potential applications. Clin J Am Soc Nephrol (2010) 0.76

Estimation of Glomerular Filtration Rate in Patients With Cirrhosis by Using New and Conventional Filtration Markers and Dimethylarginines. Clin Gastroenterol Hepatol (2015) 0.75

Automating and estimating glomerular filtration rate for dosing medications and staging chronic kidney disease. Int J Gen Med (2014) 0.75

End-stage renal disease after liver transplantation in patients with pre-transplant chronic kidney disease. Clin Transplant (2014) 0.75

Underestimation of chronic renal dysfunction after liver transplantation: ICEBERG study. World J Transplant (2015) 0.75

The use of renal replacement therapy in critically ill pediatric small bowel transplantation candidates and recipients: Experience from one center. Pediatr Transplant (2015) 0.75

Effect of low-dose tacrolimus with mycophenolate mofetil on renal function following liver transplantation. World J Gastroenterol (2014) 0.75

Portal hypertension in polycystic liver disease patients does not affect wait-list or immediate post-liver transplantation outcomes. World J Gastroenterol (2016) 0.75

Efficacy and safety of a reduced calcineurin inhibitor dose combined with mycophenolate mofetil in liver transplant patients with chronic renal dysfunction. Oncotarget (2017) 0.75

Articles by these authors

Prevalence of chronic kidney disease in the United States. JAMA (2007) 38.98

Assessing kidney function--measured and estimated glomerular filtration rate. N Engl J Med (2006) 20.27

Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet (2010) 18.36

Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation (2003) 15.79

Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis (2008) 15.04

Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis (2003) 15.00

Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med (2012) 14.99

A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med (2009) 14.13

Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med (2002) 10.52

Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem (2005) 8.93

Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol (2006) 8.61

Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol (2004) 8.21

Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med (2013) 7.98

Calibration of serum creatinine in the National Health and Nutrition Examination Surveys (NHANES) 1988-1994, 1999-2004. Am J Kidney Dis (2007) 7.86

Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis (2002) 7.03

Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA (2012) 6.26

Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int (2011) 6.01

Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension (2003) 6.01

Evaluation of the modification of diet in renal disease study equation in a large diverse population. J Am Soc Nephrol (2007) 6.00

Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int (2008) 5.90

Partial nephrectomy versus radical nephrectomy in patients with small renal tumors--is there a difference in mortality and cardiovascular outcomes? J Urol (2008) 5.70

Erythropoietic response and outcomes in kidney disease and type 2 diabetes. N Engl J Med (2010) 5.48

Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis. Ann Intern Med (2003) 5.47

Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int (2011) 5.47

The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study. Ann Intern Med (2005) 5.45

The timing of specialist evaluation in chronic kidney disease and mortality. Ann Intern Med (2002) 5.33

Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int (2011) 5.25

The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care (2007) 5.07

Impact of creatinine calibration on performance of GFR estimating equations in a pooled individual patient database. Am J Kidney Dis (2007) 5.06

Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate. N Engl J Med (2015) 5.03

Reproducibility of nerve fiber thickness, macular thickness, and optic nerve head measurements using StratusOCT. Invest Ophthalmol Vis Sci (2004) 4.81

Comparison of drug dosing recommendations based on measured GFR and kidney function estimating equations. Am J Kidney Dis (2009) 4.30

A predictive model for progression of chronic kidney disease to kidney failure. JAMA (2011) 4.22

Transmission of rabies virus from an organ donor to four transplant recipients. N Engl J Med (2005) 4.05

Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2. Am J Kidney Dis (2010) 3.87

Cystatin C identifies chronic kidney disease patients at higher risk for complications. J Am Soc Nephrol (2010) 3.85

Optical coherence tomography longitudinal evaluation of retinal nerve fiber layer thickness in glaucoma. Arch Ophthalmol (2005) 3.75

Patient awareness of chronic kidney disease: trends and predictors. Arch Intern Med (2008) 3.72

Testing for chronic kidney disease: a position statement from the National Kidney Foundation. Am J Kidney Dis (2007) 3.53

Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol (2003) 3.48

Chronic kidney disease is common: what do we do next? Nephrol Dial Transplant (2008) 3.41

Effect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. Am J Kidney Dis (2008) 3.34

Evolving importance of kidney disease: from subspecialty to global health burden. Lancet (2013) 3.30

National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification. Pediatrics (2003) 3.10

Method of glomerular filtration rate estimation affects prediction of mortality risk. J Am Soc Nephrol (2009) 3.05

Measured GFR as a confirmatory test for estimated GFR. J Am Soc Nephrol (2009) 3.00

Expressing the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) cystatin C equations for estimating GFR with standardized serum cystatin C values. Am J Kidney Dis (2011) 2.98

Uric acid and long-term outcomes in CKD. Am J Kidney Dis (2009) 2.86

Imprecision of urinary iothalamate clearance as a gold-standard measure of GFR decreases the diagnostic accuracy of kidney function estimating equations. Am J Kidney Dis (2010) 2.83

Comparing the risk for death with peritoneal dialysis and hemodialysis in a national cohort of patients with chronic kidney disease. Ann Intern Med (2005) 2.82

Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. Kidney Int (2003) 2.77

Cystatin C as a risk factor for outcomes in chronic kidney disease. Ann Intern Med (2007) 2.71

Estimating equations for glomerular filtration rate in the era of creatinine standardization: a systematic review. Ann Intern Med (2012) 2.69

Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK). Am J Kidney Dis (2003) 2.68

Cardiovascular disease and subsequent kidney disease. Arch Intern Med (2007) 2.65

Serum cystatin C in the United States: the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis (2008) 2.64

Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: primary results from the Folic Acid for Vascular Outcome Reduction in Transplantation trial. Circulation (2011) 2.62

Clinical practice guidelines in nephrology--for worse or for better. Nephrol Dial Transplant (2006) 2.58

Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study. J Am Soc Nephrol (2002) 2.58

Uric acid and incident kidney disease in the community. J Am Soc Nephrol (2008) 2.44

Estimating GFR using the CKD Epidemiology Collaboration (CKD-EPI) creatinine equation: more accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions. Am J Kidney Dis (2010) 2.41

Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study. Kidney Int (2004) 2.38

Association between body mass index and CKD in apparently healthy men. Am J Kidney Dis (2005) 2.30

Clinical practice guidelines for chronic kidney disease in adults: Part I. Definition, disease stages, evaluation, treatment, and risk factors. Am Fam Physician (2004) 2.27

Optical coherence tomography (OCT) macular and peripapillary retinal nerve fiber layer measurements and automated visual fields. Am J Ophthalmol (2004) 2.25

Anemia as a risk factor for cardiovascular disease in The Atherosclerosis Risk in Communities (ARIC) study. J Am Coll Cardiol (2002) 2.25

Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: a meta-analysis. BMJ (2013) 2.24

Pro: Estimating GFR using the chronic kidney disease epidemiology collaboration (CKD-EPI) 2009 creatinine equation: the time for change is now. Nephrol Dial Transplant (2013) 2.20

Cardiovascular outcomes and all-cause mortality: exploring the interaction between CKD and cardiovascular disease. Am J Kidney Dis (2006) 2.16

C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney Int (2005) 2.13

Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study. J Am Soc Nephrol (2005) 2.07

Association between cardiac biomarkers and the development of ESRD in patients with type 2 diabetes mellitus, anemia, and CKD. Am J Kidney Dis (2011) 2.05

Acute kidney injury following liver transplantation: definition and outcome. Liver Transpl (2009) 2.05

Liver Resection and Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria. Ann Surg (2016) 2.05

Meta-regression detected associations between heterogeneous treatment effects and study-level, but not patient-level, factors. J Clin Epidemiol (2004) 2.02

Progression risk, urinary protein excretion, and treatment effects of angiotensin-converting enzyme inhibitors in nondiabetic kidney disease. J Am Soc Nephrol (2007) 2.00

The Framingham predictive instrument in chronic kidney disease. J Am Coll Cardiol (2007) 2.00

Low rates of testing and diagnostic codes usage in a commercial clinical laboratory: evidence for lack of physician awareness of chronic kidney disease. J Am Soc Nephrol (2005) 1.98

Frequency of patient-physician contact and patient outcomes in hemodialysis care. J Am Soc Nephrol (2004) 1.97

Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study. Transplantation (2006) 1.94

Ethnic subgroup differences in hypertension in Pakistan. J Hypertens (2003) 1.94

CKD in the elderly--old questions and new challenges: World Kidney Day 2008. Am J Kidney Dis (2008) 1.93

Waist-to-hip ratio, body mass index, and subsequent kidney disease and death. Am J Kidney Dis (2008) 1.92

Albuminuria, cognitive functioning, and white matter hyperintensities in homebound elders. Am J Kidney Dis (2008) 1.91

Use of albumin creatinine ratio and urine albumin concentration as a screening test for albuminuria in an Indo-Asian population. Nephrol Dial Transplant (2007) 1.91

Changes in dietary protein intake has no effect on serum cystatin C levels independent of the glomerular filtration rate. Kidney Int (2010) 1.88

Kidney disease as a risk factor for recurrent cardiovascular disease and mortality. Am J Kidney Dis (2004) 1.88

The development of a dental diagnostic terminology. J Dent Educ (2011) 1.82

Waist-to-hip ratio and body mass index as risk factors for cardiovascular events in CKD. Am J Kidney Dis (2008) 1.82

Evaluation of the Chronic Kidney Disease Epidemiology Collaboration equation for estimating the glomerular filtration rate in multiple ethnicities. Kidney Int (2010) 1.81

Chronic kidney disease in the elderly--how to assess risk. N Engl J Med (2005) 1.81

Agreement of self-reported comorbid conditions with medical and physician reports varied by disease among end-stage renal disease patients. J Clin Epidemiol (2006) 1.79

Cryptococcus neoformans in organ transplant recipients: impact of calcineurin-inhibitor agents on mortality. J Infect Dis (2007) 1.78

Serum creatinine as marker of kidney function in South Asians: a study of reduced GFR in adults in Pakistan. J Am Soc Nephrol (2005) 1.76

Prognostic assessment of estimated glomerular filtration rate by the new Chronic Kidney Disease Epidemiology Collaboration equation in comparison with the Modification of Diet in Renal Disease Study equation. Am Heart J (2011) 1.71